Zagotenemab Uses, Dosage, Side Effects and more
Zagotenemab is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease).
| Attribute | Details |
|---|---|
| Trade Name | Zagotenemab |
| Generic | Zagotenemab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
